Drugs / Polyglucoferron
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04087993 | May → Dec 2020 | iron deficiency anemia | Dr. Frank Behrens | Withdrawn | No outcome recorded |
| Phase 3 | NCT03817957 | Sep 2018 → Dec 2023 | iron deficiency anemia | Prof. Dr. Frank Behrens | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Polyglucoferron | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04087993 ↗ |
| Route | Intravenous | “Polyglucoferron intravenously (i.v.)” NCT04087993 ↗ |